Translational Institute of Medicine Granted Provisional Approval by Queen's Senate Advisory CommitteePublished Wed Mar 29th 2017
On recommendation from Dr. Fisher and the Senate Advisory Research Committee (SARC), the Office of the Provost and Vice-Principal (Academic) has provided provisional approval for the establishment of Translational Institute of Medicine (TIME), a faculty-based research institute within Faculty of Health Sciences (FHS).
Led by Dr. Stephen Vanner (Interim Director, TIME), the concept for TIME was first presented to the DOM Faculty members at the 2015 Fall Annual Retreat and was made strategic priority by the DOM Executive. Moreover, the creation of TIME aligns with the Queen’s University Strategic Framework’s commitment to strengthen the University’s research prominence, and is a specific aim in the FHS five-year strategic plan (2017-2022).
TIME is a new research model that will elevate the visibility of the Faculty of Health Sciences’ biomedical research enterprise and competitiveness. By bringing together a highly skilled research community – within DOM along with their collaborators across FHS and other Queen’s faculties, and their National/International Institutional and Industrial partners – TIME will optimize expertise and state-of-the-art research platforms, improve collaboration and enhance access to technology and infrastructure resources including Queen’s Cardiopulmonary Unit (QCPU), Gastrointestinal Diseases Research Unit (GIDRU) and Environmental Exposure Unit (EEU). Development is underway for an electronic ‘atlas’ that serves to identify and pinpoint the “Who is Where” and “What is Where” of researchers and infrastructure resources for an enhanced, more transparent and more accessible research network.
Alongside the creation of TIME is the development of a Translational Medicine Graduate Program (MSc. and PhD), led by Dr. Paula James. Under this novel new program, students will operate at the intersection of clinical and basic sciences and will acquire the necessary skills for translating research into enhanced patient care, health policy and accelerated biomedical discovery. The new graduate program has received pre-approval from the Graduate Studies Executive Council (GSEC) to proceed with a full application.
The announcement of provisional approval is an exciting step forward for the creation of TIME, which is increasingly recognized by Queen’s leadership and across FHS as an important opportunity for enhancing visibility and competitiveness to benefit our collective research capacity and role as a research-intensive university.